156 related articles for article (PubMed ID: 16407287)
21. Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein.
Takahashi H; Houghten R; Putney SD; Margulies DH; Moss B; Germain RN; Berzofsky JA
J Exp Med; 1989 Dec; 170(6):2023-35. PubMed ID: 2479705
[TBL] [Abstract][Full Text] [Related]
22. Inactivation of human immunodeficiency virus (HIV)-1 envelope-specific CD8+ cytotoxic T lymphocytes by free antigenic peptide: a self-veto mechanism?
Takahashi H; Nakagawa Y; Leggatt GR; Ishida Y; Saito T; Yokomuro K; Berzofsky JA
J Exp Med; 1996 Mar; 183(3):879-89. PubMed ID: 8642292
[TBL] [Abstract][Full Text] [Related]
23. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
Lapham C; Golding B; Inman J; Blackburn R; Manischewitz J; Highet P; Golding H
J Virol; 1996 May; 70(5):3084-92. PubMed ID: 8627787
[TBL] [Abstract][Full Text] [Related]
24. Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens.
Schirmbeck R; Deml L; Melber K; Wolf H; Wagner R; Reimann J
Vaccine; 1995 Jun; 13(9):857-65. PubMed ID: 7483809
[TBL] [Abstract][Full Text] [Related]
25. Presentation and binding affinity of equine infectious anemia virus CTL envelope and matrix protein epitopes by an expressed equine classical MHC class I molecule.
McGuire TC; Leib SR; Mealey RH; Fraser DG; Prieur DJ
J Immunol; 2003 Aug; 171(4):1984-93. PubMed ID: 12902502
[TBL] [Abstract][Full Text] [Related]
26. Intracellular delivery of a cytolytic T-lymphocyte epitope peptide by pertussis toxin to major histocompatibility complex class I without involvement of the cytosolic class I antigen processing pathway.
Carbonetti NH; Irish TJ; Chen CH; O'Connell CB; Hadley GA; McNamara U; Tuskan RG; Lewis GK
Infect Immun; 1999 Feb; 67(2):602-7. PubMed ID: 9916065
[TBL] [Abstract][Full Text] [Related]
27. The common equine class I molecule Eqca-1*00101 (ELA-A3.1) is characterized by narrow peptide binding and T cell epitope repertoires.
Bergmann T; Moore C; Sidney J; Miller D; Tallmadge R; Harman RM; Oseroff C; Wriston A; Shabanowitz J; Hunt DF; Osterrieder N; Peters B; Antczak DF; Sette A
Immunogenetics; 2015 Nov; 67(11-12):675-89. PubMed ID: 26399241
[TBL] [Abstract][Full Text] [Related]
28. Immunization of mice with human immunodeficiency virus glycoprotein gp160 peptide 315-329 induces both class I- and class II-restricted T cells: not all T cells can respond to whole molecule stimulation.
Moore RL; Fox BS
AIDS Res Hum Retroviruses; 1993 Jan; 9(1):51-9. PubMed ID: 7678972
[TBL] [Abstract][Full Text] [Related]
29. Role of conserved regions of class I MHC molecules in the activation of CD8+ cytotoxic T lymphocytes by peptide and purified cell-free class I molecules.
Takeshita T; Kozlowski S; England RD; Brower R; Schneck J; Takahashi H; DeLisi C; Margulies DH; Berzofsky JA
Int Immunol; 1993 Sep; 5(9):1129-38. PubMed ID: 8241055
[TBL] [Abstract][Full Text] [Related]
30. A modern approach for epitope prediction: identification of foot-and-mouth disease virus peptides binding bovine leukocyte antigen (BoLA) class I molecules.
Pandya M; Rasmussen M; Hansen A; Nielsen M; Buus S; Golde W; Barlow J
Immunogenetics; 2015 Nov; 67(11-12):691-703. PubMed ID: 26496773
[TBL] [Abstract][Full Text] [Related]
31. In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides.
Zhou X; Abdel Motal UM; Berg L; Jondal M
Eur J Immunol; 1992 Dec; 22(12):3085-90. PubMed ID: 1446701
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the role of bleomycin hydrolase in antigen presentation and the generation of CD8 T cell responses.
Towne CF; York IA; Watkin LB; Lazo JS; Rock KL
J Immunol; 2007 Jun; 178(11):6923-30. PubMed ID: 17513741
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of T-cell responses to peptides and lipopeptides with MHC class I binding motifs derived from the amino acid sequence of the 19-kDa lipoprotein of Mycobacterium tuberculosis.
Fonseca DP; Joosten D; Snippe H; Verheul AF
Mol Immunol; 2000 Jun; 37(8):413-22. PubMed ID: 11090876
[TBL] [Abstract][Full Text] [Related]
34. Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway.
Peng S; Frazer IH; Fernando GJ; Zhou J
Virology; 1998 Jan; 240(1):147-57. PubMed ID: 9448699
[TBL] [Abstract][Full Text] [Related]
35. ERAAP and tapasin independently edit the amino and carboxyl termini of MHC class I peptides.
Kanaseki T; Lind KC; Escobar H; Nagarajan N; Reyes-Vargas E; Rudd B; Rockwood AL; Van Kaer L; Sato N; Delgado JC; Shastri N
J Immunol; 2013 Aug; 191(4):1547-55. PubMed ID: 23863903
[TBL] [Abstract][Full Text] [Related]
36. Heat shock protein-chaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by major histocompatibility complex I molecules.
Binder RJ; Blachere NE; Srivastava PK
J Biol Chem; 2001 May; 276(20):17163-71. PubMed ID: 11278929
[TBL] [Abstract][Full Text] [Related]
37. A synthetic peptide from the first conserved region in the envelope protein gp160 is a strong T-cell epitope in HIV-infected chimpanzees and humans.
Nehete PN; Schapiro SJ; Johnson PC; Murthy KK; Satterfield WC; Sastry KJ
Viral Immunol; 1998; 11(3):147-58. PubMed ID: 9918406
[TBL] [Abstract][Full Text] [Related]
38. Characterizing the N-terminal processing motif of MHC class I ligands.
Schatz MM; Peters B; Akkad N; Ullrich N; Martinez AN; Carroll O; Bulik S; Rammensee HG; van Endert P; Holzhütter HG; Tenzer S; Schild H
J Immunol; 2008 Mar; 180(5):3210-7. PubMed ID: 18292545
[TBL] [Abstract][Full Text] [Related]
39. Competitive inhibition in vivo and skewing of the T cell repertoire of antigen-specific CTL priming by an anti-peptide-MHC monoclonal antibody.
Chung DH; Belyakov IM; Derby MA; Wang J; Boyd LF; Berzofsky JA; Margulies DH
J Immunol; 2001 Jul; 167(2):699-707. PubMed ID: 11441073
[TBL] [Abstract][Full Text] [Related]
40. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.
Morkowski S; Goldrath AW; Eastman S; Ramachandra L; Freed DC; Whiteley P; Rudensky AYu
J Exp Med; 1995 Nov; 182(5):1403-13. PubMed ID: 7595211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
